Evidence map›Paper›PMID 41038373›Full record

ArticleFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association2026

Reverse-engineered exclusive enteral nutrition as induction therapy in pediatric Crohn's disease: Effects on environmental toxin exposure.

Elizabeth A Reznikov, Melissa M Melough, Dale Y Lee, David L Suskind, Shar Samy, James MacDonald, Theo K Bammler, Sheela Sathyanarayana

Abstract read
In one paragraph

Article in Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elizabeth A ReznikovDepartment of Pediatrics, Division of Gastroenterology, Seattle Children's Hospital and University of Washington, Seattle, WA, USA. Electronic address: elizabeth.reznikov@seattlechildrens.org.
Melissa M MeloughDepartment of Health Behavior and Nutrition Sciences, University of Delaware, Newark, DE, USA.
Dale Y LeeDepartment of Pediatrics, Division of Gastroenterology, Seattle Children's Hospital and University of Washington, Seattle, WA, USA.
David L SuskindDepartment of Pediatrics, Division of Gastroenterology, Seattle Children's Hospital and University of Washington, Seattle, WA, USA.
Shar SamyDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
James MacDonaldDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
Theo K BammlerDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
Sheela SathyanarayanaDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA; Center for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA.

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI Joel Daniel Kaufman · 1995 to 2026
$42.5M
University of Washington Pediatric and Reproductive Environmental Health Scholars (UW PREHS)K12ES033584 · NIEHS · UNIVERSITY OF WASHINGTON · PI CATHERINE J KARR, Sheela Sathyanarayana · 2022 to 2026
$2.4M
NIEHS NIH HHS K12 ES033584NIEHS NIH HHS P30 ES007033
6 · The paper itself

Abstract

Exclusive Enteral Nutrition (EEN) can induce remission in Crohn's disease (CD). We completed a pilot study using novel reverse-engineered EEN (RE-EEN), a whole food smoothie in place of commercial liquid formula (EEN) which contains food additives to improve shelf stability and palatability. In a four week trial with RE-EEN, we reported 80 % of patients went into clinical remission after four weeks. We hypothesized RE-EEN would decrease environmental toxin exposure through reduction of processing food intake. Biosamples were collected at baseline and at weeks two, four, and eight during the RE-EEN study. Urinary heavy metals were analyzed by inductively coupled plasma mass spectrometry, and urinary phthalate metabolites and melamine by liquid chromatography with tandem mass spectrometry. For our primary analysis, change in baseline was calculated using a paired t-test for week four. Analysis was also completed for all weeks on RE-EEN using a generalized least squares model. Results were expressed as fold change ± standard error mean. Paired t-testing demonstrated a statistically significant (p < 0.05) effect on molybdenum (Mo) with a fold change of 0.17 ± 0.15, an 83 % reduction following RE-EEN treatment. Our results suggested an effect of arsenic (As) with fold change of 0.23 ± 0.26 (p = 0.12), a 77 % reduction following RE-EEN treatment. Our results also suggested an effect of cobalt (Co) with a fold change of 3.12 ± 3.12 fold, a 212 % increase following RE-EEN therapy (p = 0.16). With inclusion of all weeks on RE-EEN, Mo and As were statistically significant (p < 0.05). Overall, we observed favorable shifts in urinary heavy metals by week four, and no effects were suggested in phthalate and melamine analysis. We saw increased precision in a sensitivity analysis when including all weeks for treatment. This is the first study to examine environmental toxicants in relation to whole foods smoothie diet in pediatric CD. RE-EEN dietary intervention shows promise in reducing chemical exposures and may contribute to CD remission. Notable limitations to this research include small sample size and absence of a control group. Further studies are necessary to assess the impact of RE-EEN diet on environmental toxicant exposure.

Indexed as

Crohn DiseaseEnteral NutritionEnvironmental ExposureAdolescentChildFemaleHumansMaleMetals, HeavyMolybdenumPhthalic AcidsPilot ProjectsTriazinesmelamineMetals, HeavyMolybdenumPhthalic AcidsTriazinesHeavy metalsInflammatory bowel diseaseNutrition

Identifiers

PMID41038373
PMCPMC12640686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.